CXCL13-neutralizing Antibody Alleviate Chronic Skeletal Muscle Degeneration in a Mouse Model

CONCLUSION: Our study reveals the underlying therapeutic implications of CXCL13 inhibition for clinical intervention in skeletal muscle degeneration, thereby improving patient prognosis.PMID:38500285 | DOI:10.2174/0115665240275029240306045214

Source: Current Molecular Medicine - March 19, 2024 Category: Molecular Biology Authors: Zhongcheng Xie Jimin Yang Chunmeng Jiao Hui Chen Siyu Ouyang Zhiyang Liu Qin Hou Jifeng Liu Source Type: research